Jianfeng Group announced that Anhui Jianfeng North Carolina Pharmaceutical Co., Ltd., a subsidiary of the company, received the “Notice of Approval of the Chemical Ingredient Application for the Marketing Application” of the chemical ingredient methyldopa from the State Drug Administration, indicating that the API has met relevant national evaluation technical standards and can be sold in the domestic market, which helps expand the subsidiary's business field.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.